Last updated on March 2019

Safety Tolerability Pharmacokinetics and Activity of K0706

Brief description of study

Phase 1/2 study to determine safety, tolerability, pharmacokinetics and activity of K0706

Detailed Study Description

Part A ( for Healthy volunteers) of the study is completed Part B (for CML subject ) of the study is ongoing. (Recruitment for Part B initiated in April 2017) Part C of study in subjects with CML and Ph+ ALL is to be initiated. (Recruitment for Part C is to be initiated.)

Clinical Study Identifier: NCT02629692

Contact Investigators or Research Sites near you

Start Over

Sun Pharma Advanced Research Company ...

SPARC Site 5
Tours Cedex 9, France
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.